EAM

Exome Asset Management Portfolio holdings

AUM $110M
1-Year Est. Return 24.83%
This Quarter Est. Return
1 Year Est. Return
+24.83%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$112M
AUM Growth
-$21.3M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
78
New
Increased
Reduced
Closed

Top Buys

1
+$4.73M
2
+$3.72M
3
+$2.93M
4
RGNX icon
Regenxbio
RGNX
+$2.9M
5
DYN icon
Dyne Therapeutics
DYN
+$2.7M

Top Sells

1
+$4.58M
2
+$4.46M
3
+$3.81M
4
BMY icon
Bristol-Myers Squibb
BMY
+$3.69M
5
BSX icon
Boston Scientific
BSX
+$3.62M

Sector Composition

1 Healthcare 98.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GEHC icon
26
GE HealthCare
GEHC
$34.7B
$2.05M 1.82%
+25,400
FULC icon
27
Fulcrum Therapeutics
FULC
$525M
$1.98M 1.76%
689,137
+405,538
GPCR icon
28
Structure Therapeutics
GPCR
$1.55B
$1.78M 1.58%
102,944
-49,021
IMNM icon
29
Immunome
IMNM
$1.46B
$1.78M 1.58%
+263,841
ONC
30
BeOne Medicines Ltd
ONC
$34.7B
$1.77M 1.57%
6,500
-3,500
CRNX icon
31
Crinetics Pharmaceuticals
CRNX
$4.04B
$1.72M 1.53%
+51,295
EWTX icon
32
Edgewise Therapeutics
EWTX
$1.63B
$1.57M 1.4%
71,438
-10,035
RDY icon
33
Dr. Reddy's Laboratories
RDY
$12.3B
$1.55M 1.38%
117,500
CRBP icon
34
Corbus Pharmaceuticals
CRBP
$237M
$1.54M 1.37%
+289,690
NKTR icon
35
Nektar Therapeutics
NKTR
$1.13B
$1.52M 1.35%
148,830
+107,618
ARVN icon
36
Arvinas
ARVN
$709M
$1.37M 1.22%
195,295
-23,405
GOSS icon
37
Gossamer Bio
GOSS
$499M
$1.21M 1.07%
1,097,999
TRVI icon
38
Trevi Therapeutics
TRVI
$1.3B
$1.03M 0.92%
+163,738
MBX
39
MBX Biosciences
MBX
$685M
$982K 0.87%
+133,113
BHVN icon
40
Biohaven
BHVN
$1.88B
$959K 0.85%
39,900
+11,741
ALVO icon
41
Alvotech
ALVO
$2.65B
$871K 0.77%
90,100
VYNE icon
42
VYNE Therapeutics
VYNE
$9.23M
$731K 0.65%
462,801
+109,367
ESTA icon
43
Establishment Labs
ESTA
$1.43B
$535K 0.48%
13,100
BCRX icon
44
BioCryst Pharmaceuticals
BCRX
$1.47B
$455K 0.4%
+60,600
ELDN icon
45
Eledon Pharmaceuticals
ELDN
$209M
$387K 0.34%
114,145
-142,228
AKBA icon
46
Akebia Therapeutics
AKBA
$827M
$363K 0.32%
189,087
-16,869
NUVB icon
47
Nuvation Bio
NUVB
$1.44B
$170K 0.15%
+96,311
APRE icon
48
Aprea Therapeutics
APRE
$8.8M
$59.1K 0.05%
28,972
-98,988
SLRN
49
DELISTED
ACELYRIN
SLRN
– –
-234,435
SMMT icon
50
Summit Therapeutics
SMMT
$14B
– –
-130,412
1
2
3 4